Contract 75N93024D00022
Texas Biomedical Research Institute · Department Of Health And Human Services · July 10, 2024
Texas Biomedical Research Institute was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 10, 2024 for an undisclosed amount of work in research and development in biotechnology (except nanobiotechnology). It was awarded under full and open competition. It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. If all options are exercised, the contract could reach $146.30 million.
Contract details
- PIID
- 75N93024D00022
- Award type
- —
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- First action
- July 10, 2024
Description
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES TASK AREA PART A, B, AND C
Modification timeline
-
July 10, 2024Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93024D00022?
Contract 75N93024D00022 is a federal contract awarded to Texas Biomedical Research Institute by Department Of Health And Human Services on July 10, 2024 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75N93024D00022?
Texas Biomedical Research Institute won contract 75N93024D00022 from Department Of Health And Human Services.
How much is contract 75N93024D00022 worth?
Contract 75N93024D00022 has obligated $0 to date but carries a potential ceiling of $146.30 million if fully funded and all options are exercised.